Targeting interventions to high-risk populations: Benefits and costs

Socio-Economic Planning Sciences

Volumn 39, Issue 4, 2005, Pages 335-349

  Wilson, Amy R ^a   Kahn, James G ^b   Oren, Shmuel S ^c  

^a UNIVERSITY OF MINNESOTA   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

^c DEPARTMENT OF INDUSTRIAL ENGINEERING AND OPERATIONS RESEARCH   (United States)

Author keywords

Cost effectiveness; HIV prevention; Injection drug users; Intervention targeting; Resource allocation

Indexed keywords

HEALTH CARE; HUMAN IMMUNODEFICIENCY VIRUS; TARGETING;

HUMAN IMMUNODEFICIENCY VIRUS;

EID: 20344381536     PISSN: 00380121     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.seps.2004.05.002     Document Type: Article

References (29)

1. R.H. Brook J.E. Ware Jr. W.H. Rogers E.B. Keeler A.R. Davies C.A. Donald G.A. Goldberg K.N. Lohr P.C. Masthay J.P. Newhouse Does free care improve adults' health? Results from a randomized controlled trial New England Journal of Medicine 309 1983 1426-1434
2. A.E. Benjamin A normative analysis of home care goals Journal of Aging & Health 11 1999 445-468
3. R. Carter K.N. Mendis D. Roberts Spatial targeting of interventions against malaria Bulletin of the World Health Organization 78 2000 1401-1411
4. J.G. Kahn The cost-effectiveness of HIV prevention targeting: How much more bang for the buck? American Journal of Public Health 86 1996 1709-1712
5. B.P. Loevinsohn R.W. Sutter M.O. Costales Using cost-effectiveness analysis to evaluate targeting strategies: The case of vitamin A supplementation Health Policy and Planning 12 1997 29-37
6. J.E. Anderson R.W. Wilson P. Barker L. Doll T.S. Jones D. Holtgrave Prevalence of sexual and drug-related HIV risk behaviors in the US adult population: Results of the 1996 national household survey on drug abuse Journal of Acquired Immune Deficiency Syndromes and Human Retrovirology 21 1999 148-156
7. S.H. Dinwiddie L. Cottler W. Compton A.B. Abdallah Psychopathology and HIV risk behaviors among injection drug users in and out of treatment Drug and Alcohol Dependence 43 1996 1-11
8. C.S. Murrill D.R. Prevots M.S. Miller L.A. Linley J.E. Royalty M. Gwinn Incidence of HIV among injection drug users entering drug treatment programs in four US cities Journal of Urban Health 78 2001 152-161
9. L.M. Camacho N.G. Bartholomew G.W. Joe D.D. Simpson Maintenance of HIV risk reduction among injection opioid users: A 12 month posttreatment follow-up Drug and Alcohol Dependence 47 1997 11-18
10. S.D. Holmberg The estimated prevalence and incidence of HIV in 96 large US metropolitan areas American Journal of Public Health 86 1996 642-654
11. San Francisco HIV prevention plan. HIV Prevention Planning Council and San Francisco Department of Public Health - AIDS Office. http://www.dph.sf.ca.us/HIVPrevPlan/page2.htm: [accessed 24.03.04].
12. A.R. Wilson J.G. Kahn Preventing HIV in IDUs: Choosing the best mix of interventions for the population Journal of Urban Health 80 2003 465-481
13. A.R. Wilson J.G. Kahn Preventing HIV in IDUs: Exploring the trade-offs between interventions Socio-Economic Planning Sciences 37 2003 269-288
14. G.S. Zaric M.L. Brandeau Optimal investment in a portfolio of HIV prevention programs Medical Decision Making 21 2001 391-408
15. Sisk JE, Hatziandreu EJ, Hughes R. The effectiveness of drug abuse treatment: Implications for controlling AIDS/HIV infection (Background paper 6). Office of Technology Assessment, Series on AIDS-Related Issues. Washington, DC: United States Congress, Office of Technology Assessment; 1990.
16. E.C. Norton R.F. Martin W.M. Wechsberg Threshold analysis of AIDS outreach and intervention In: D.R. Holtgrave (Ed.), Handbook of economic evaluation of HIV prevention programs 1998 Plenum Press New York
17. W.W. Wiebel A. Jimenez W. Johnson L. Ouellet B. Jovanovic T. Lampinen J. Murray M.U. O'Brien Risk behavior and HIV seroincidence among out-of-treatment injection drug users: A four-year prospective study Journal of Acquired Immune Deficiency Syndromes and Human Retrovirology 12 1996 282-289
18. E.H. Kaplan Modeling HIV infectivity: Must sex acts be counted? Journal of Acquired Immune Deficiency Syndromes and Human Retrovirology 3 1990 55-61
19. Barnett PG, Rodgers JH, The cost of US substance abuse treatment from national survey data; 1999. Unpublished data.
20. J.K. Watters M.J. Estilo G.L. Clark J. Lorvick Syringe and needle exchange as HIV/AIDS prevention for injection drug users Journal of the American Medical Association 271 1994 115-120
21. S. King-Spooner HIV prevention and the positive population International Journal of STD and AIDS 10 1999 141-150
22. M. Ruiz A. Gable E. Kaplan M. Stoto H. Fineberg J. Trussel No Time to Lose: Getting More from HIV Prevention 2001 National Academy Press Washington, DC
23. R.S. Janssen D.F. Holtgrave R.O. Valdiserri M. Shepherd H.D. Gayle K.M. De Cock The serostatus approach to fighting the HIV epidemic: Prevention strategies for infected individuals American Journal of Public Health 91 2001 1019-1024
24. J. Ball E. Corty H. Bond C. Myers A. Tommasello The reduction of intravenous heroin use, non-opiate abuse and crime during methadone maintenance treatment: Further findings In: L.S. Harris (Ed.), NIDA Research Monograph 81. Problems of Drug Dependence 1987 1988 National Institute on Drug Abuse Rockville, MD
25. J.C. Ball W.R. Lange P.C. Myers S.R. Friedman Reducing the risk of AIDS through methadone maintenance treatment Journal of Health and Social Behavior 29 1988 214-226
26. L.M. Camacho N.G. Bartholomew G.W. Joe M.A. Cloud D.D. Simpson Gender, cocaine and during-treatment HIV risk reduction among injection opioid users in methadone maintenance Drug and Alcohol Dependence 41 1996 1-7
27. R.E. Booth C.F. Kwiatkowski R.C. Stephens Effectiveness of HIV/AIDS interventions on drug use and needle risk behaviors for out-of-treatment injection drug users Journal of Psychoactive Drugs 30 1998 269-278
28. Iguchi MY, Bux DA, Platt JJ, Lidz V, Kushner H, Baxter R, French J. Reduction in high-risk behaviors in IDUs at 6-month follow-up. In: Poster Presentation at the Third Annual Meeting of the NADR (National AIDS Demonstration Research) Project. 29-31 October 1991, Rockville, MD.
29. J.R. Watters M. Downing P. Case J. Lorvick Y. Cheng B. Fergusson AIDS prevention for intravenous drug users in the community: Street-based education and risk behavior American Journal of Community Psychology 18 1990 587-596